MedTrace Logo

To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.

NCT01381341 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2012-03-23

No results posted yet for this study

Summary

A pharmacokinetic study to compare 2 clinical formulations of linifanib.

Conditions

Interventions

DRUG

linifanib

QD on Day 1 of Periods 1 and 2

Sponsors & Collaborators

Principal Investigators

  • Mark D. McKee, MD · Abbott

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01381341 on ClinicalTrials.gov